IBB
Closed
Ishares Biotechnology Etf
127.63
+1.12 (+0.89%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 126.51
Day's Range: 125.7 - 129.95
Send
sign up or login to leave a comment!
When Written:
129.77
The iShares Biotechnology ETF (IBB) is an exchange-traded fund that tracks the performance of the biotechnology industry. It is managed by BlackRock Inc. and was launched in February 2001.
The IBB ETF is designed to provide exposure to companies involved in the development and production of drugs, medical devices, and other healthcare-related products. It invests in a diversified portfolio of biotechnology companies, including both large-cap and mid-cap firms.
The fund has a net expense ratio of 0.46%, which is relatively low compared to other biotech ETFs. As of June 2021, the IBB ETF had total assets of over $10 billion and held over 200 different stocks.
Investors can buy and sell shares of the IBB ETF on major stock exchanges, such as the New York Stock Exchange (NYSE) and NASDAQ. The ETF is considered a popular choice for investors seeking exposure to the biotechnology industry, as it provides a diversified portfolio of stocks and is relatively low-cost.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The IBB ETF is designed to provide exposure to companies involved in the development and production of drugs, medical devices, and other healthcare-related products. It invests in a diversified portfolio of biotechnology companies, including both large-cap and mid-cap firms.
The fund has a net expense ratio of 0.46%, which is relatively low compared to other biotech ETFs. As of June 2021, the IBB ETF had total assets of over $10 billion and held over 200 different stocks.
Investors can buy and sell shares of the IBB ETF on major stock exchanges, such as the New York Stock Exchange (NYSE) and NASDAQ. The ETF is considered a popular choice for investors seeking exposure to the biotechnology industry, as it provides a diversified portfolio of stocks and is relatively low-cost.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!